Evidence map›Paper›PMID 19154720›Full record

ArticleDevelopmental cell2009

Dystroglycan and perlecan provide a basal cue required for epithelial polarity during energetic stress.

Vincent Mirouse, Christina P Christoforou, Cornelia Fritsch, Daniel St Johnston, Robert P Ray

RetractedAbstract readRetracted Publication
In one paragraph

Article in Developmental cell, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Translating cell polarity into tissue elongation.Seminars in cell & developmental biology · 2011
    Review
  16. Article
  17. Principles of planar polarity in animal development.Development (Cambridge, England) · 2011
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Vincent MirouseThe Gurdon Institute and the Department of Genetics, University of Cambridge, Cambridge, UK.
Christina P Christoforou
Cornelia Fritsch
Daniel St Johnston
Robert P Ray
University of Cambridge · GB

Funding

Biotechnology and Biological Sciences Research CouncilCancer Research UK A14492Medical Research Council G0500916Wellcome Trust 080007Wellcome Trust 092096
6 · The paper itself

Abstract

Dystroglycan localizes to the basal domain of epithelial cells and has been reported to play a role in apical-basal polarity. Here, we show that Dystroglycan null mutant follicle cells have normal apical-basal polarity, but lose the planar polarity of their basal actin stress fibers, a phenotype it shares with Dystrophin mutants. However, unlike Dystrophin mutants, mutants in Dystroglycan or in its extracellular matrix ligand Perlecan lose polarity under energetic stress. The maintenance of epithelial polarity under energetic stress requires the activation of Myosin II by the cellular energy sensor AMPK. Starved Dystroglycan or Perlecan null cells activate AMPK normally, but do not activate Myosin II. Thus, Perlecan signaling through Dystroglycan may determine where Myosin II can be activated by AMPK, thereby providing the basal polarity cue for the low-energy epithelial polarity pathway. Since Dystroglycan is often downregulated in tumors, loss of this pathway may play a role in cancer progression.

Indexed as

Epithelial CellsStress, PhysiologicalAMP-Activated Protein KinasesAnimalsCell PolarityDrosophila melanogasterDrosophila ProteinsDystroglycansFemaleHeparan Sulfate ProteoglycansHumansMaleMyosin Type IIOocytesOvarian FolliclePhenotypeAMP-Activated Protein KinasesDrosophila ProteinsDystroglycansHeparan Sulfate ProteoglycansMyosin Type IIperlecan

Identifiers

PMID19154720
PMCPMC2789236
OpenAlexW2159952016

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.